haku: @indexterm bio-technology / yhteensä: 177
viitteet: 13-22 / 177
« edellinen sivu | seuraava sivu »
 otsikkovuositekijä
13.
The evolution of the phar maceutical-biotechnology industry
Business history
2008 : SEP, VOL. 50:5, p. 583-601
 2008 Gottinger, H-W.
Umali, C.L.
14.
Investing in consumer confidence through genetically modified labelling: An evaluation of compliance options and their marketing challenges for Australian firms
Journal of Marketing Management
2008 : JUL, VOL. 24:5-6, p. 621-635
 2008 D'Sousa, C. (et al.)
15.
Qualified ageing workers in the knowledge management process of high-tech businesses
Journal of Knowledge Management
2008 : VOL. 12:2, p. 124-140
 2008 Ebrahimi, M.
Saives, A-L.
Holford, W.D.
16.
Biotech as "biothreat"?: metaphorical constructions in discourse
Discourse & Society
2008 : JAN, VOL. 19:1, p. 99-119
 2008 Holmgreen, L.-L.
17.
Know-how transfer: the role of social, economic/competitive, and firm boundary factors
Strategic Management Journal
2008 : APR, VOL. 29:4, p. 425-445
 2008 Kachra, A.
White, R.E.
18.
The role of pest resistance in biotechnology R&D investment strategy
Journal of Environmental Economics and Management
2008 : MAR, VOL. 55:2, p. 213-228
 2008 O'Shea, L.
Ulph, A.
19.
Managing the risks associated with using biomedical ethics advice
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 99-109
 2008 Eaton, M. L.
20.
Marketing in Heterozygous advantage
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 85-97
 2008 Jones, G. T.
Hagtwedt, R.
21.
Canada's stem cell corporation: Aggregate concerns and the question of public trust
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.73-84
 2008 Herder, M.
Brian, J. D.
22.
Sowing the seeds of reason in the field of the terminator debate
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.65-72
 2008 Bustos, K.
« edellinen sivu | seuraava sivu »
SCIMA